Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Cardiac disorder, Heart rate irregular, Inappropriate schedule of product administration, Off label use
Clinical narrative: fist dose on 19Apr2021, second dose on 03May2021; fist dose on 19Apr2021, second dose on 03May2021; Irregular pulse; a cardiac patient; This is spontaneous report from contactable consumer. This 54 year-old female consumer (patient) reported that: report about covid_vaccine: Yes reporting type: AE reporter type: Patient if other vaccine in four weeks No other medication in two weeks Methylphenidate Hydrochloride adverse event start date 26Apr2021 if patient recovered: Not recovered other medical history: asthma fibromyalgia  Drug(s) Information: Proprietary medicinal product name: Pfizer Batch/lot number: EW0161 Date of start of drug: 19-Apr-2021 Anatomical Location: Arm Left Dose Number: 2  Proprietary medicinal product name: Pfizer Batch/lot number: ER8730 Date of start of drug: 03-May-2021 Anatomical Location: Arm Left Dose Number: 1  Start Date/Time: [Pfizer] 19-APR-2021 06:00 PM Start Date/Time: [Pfizer] 3-MAY-2021 12:00 PM  Facility where the most recent COVID-19 vaccine was administered:Doctor's office/urgent care Did the patient receive any other vaccines within 4 weeks prior to the COVID vaccine:No List of any other medications the patient received within 2 weeks of vaccination:Methylphenidate Hydrochloride   Reported Event: Irregular pulse started about a week after the second vaccine, went to emergency room on Monday, 5/6 because symptoms were getting worse. Am now a cardiac patient.  Did the adverse event result in any of the following?: Doctor or other healthcare professional office/clinic visit Did the adverse event result in any of the following?: Emergency room/department or urgent care What treatment received for the adverse event? cardiac monitoring  Prior to vaccination, was the patient diagnosed with COVID-19?:No Since the vaccination, has the patient been tested for COVID-19?:No Device Date : 06May2021 Information on Lot/Batch number was available. Additional information has been requested This is a spontaneous report from a contactable consumer or other non hcp.   A 54-years-old female patient received bnt162b2 (BNT162B2), dose 2 via an unspecified route of administration, administered in Arm Left on 03May2021 12:00 (Batch/Lot Number: EW0161) as SINGLE DOSE for covid-19 immunisation  .  Medical history included asthma fibromyalgia from an unknown date and unknown if ongoing. Concomitant medication(s) included methylphenidate hydrochloride (METHYLPHENIDATE HYDROCHLORIDE BRECKENRIDGE) taken for an unspecified indication, start and stop date were not reported.  The patient experienced irregular pulse started about a week after the second vaccine, went to emergency room on monday, 5/6 because symptoms were getting worse. am now a cardiac patient. (heart rate irregular) (medically significant) on 26Apr2021 with outcome of not recovered , irregular pulse started about a week after the second vaccine, went to emergency room on monday, 5/6 because symptoms were getting worse. am now a cardiac patient. (cardiac disorder) (medically significant) on 26Apr2021 with outcome of not recovered , fist dose on 19apr2021, second dose on 3may2021 (inappropriate schedule of product administration) (non-serious) on an unspecified date with outcome of unknown.  The action taken in response to the event(s) for bnt162b2 was not applicable.  Therapeutic measures were taken as a result of irregular pulse started about a week after the second vaccine, went to emergency room on monday, 5/6 because symptoms were getting worse. am now a cardiac patient. (heart rate irregular), irregular pulse started about a week after the second vaccine, went to emergency room on monday, 5/6 because symptoms were getting worse. am now a cardiac patient. (cardiac disorder).